Search - tctmd.com

Displaying 41 - 60 of 477

Sort: Relevancy | Date

Presentation TCT 2022

EXpansion of Stents After Intravascular lithoTripsy vs Conventional Predilatation in CALCified Coronary Arteries

Presenter: Maarten Vink

September 19, 2022

Presentation TCT 2022

Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial

Presenter: Rania Hammami

September 19, 2022

Presentation TCT 2022

Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Presenter: Shamir Mehta

September 19, 2022

Presentation TCT 2022

Survival After PCI or CABG for Left Main Coronary Disease: A Report From the Swedish Coronary Angiography and Angioplasty Registry

Presenter: Elmir Omerovic

September 19, 2022

Presentation TCT 2022

Current Medical Therapy Is the Gold Standard for Plaque Stabilization

Presenter: David J. Cohen

September 18, 2022

Presentation TCT 2022

P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?

Presenter: Davide Capodanno

September 18, 2022

Presentation TCT 2022

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Presenter: Christos Rammos

September 17, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

News Conference News TCT 2021

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

Yael L. Maxwell

November 09, 2021

Presentation TCT 2021

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

Presenter: IN-HO CHAE

November 06, 2021

Presentation TCT 2021

BIO-RISE CHINA: A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease

Presenter: Yaling Han

November 06, 2021

News Conference News TCT 2021

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

Caitlin E. Cox

November 06, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

Presentation TCT 2021

MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy - Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk

Presenter: Pieter Smits

November 05, 2021

Presentation TCT 2021

Disrupt CAD Pooled Female vs Male Analysis

Presenter: Alexandra Lansky

November 05, 2021

Presentation TCT 2021

Disrupt CAD Pooled Nodular Calcium Analysis

Presenter: Akiko Maehara

November 05, 2021

Presentation TCT 2021

Disrupt CAD Pooled Eccentric vs Concentric Analysis

Presenter: Ziad Ali

November 05, 2021

Presentation TCT 2021

Disrupt CAD III 1yr Data

Presenter: Matthew Price

November 05, 2021

Presentation TCT 2021

Introduction & MOA Overview

Presenter: Ziad Ali

November 05, 2021

Advertisement

EXpansion of Stents After Intravascular lithoTripsy vs Conventional Predilatation in CALCified Coronary Arteries

Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial

Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Survival After PCI or CABG for Left Main Coronary Disease: A Report From the Swedish Coronary Angiography and Angioplasty Registry

Current Medical Therapy Is the Gold Standard for Plaque Stabilization

P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

BIO-RISE CHINA: A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

More DAPT Duration Data, More Calls to Tailor to Individual Patients

MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy - Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk

Disrupt CAD Pooled Female vs Male Analysis

Disrupt CAD Pooled Nodular Calcium Analysis

Disrupt CAD Pooled Eccentric vs Concentric Analysis

Disrupt CAD III 1yr Data

Introduction & MOA Overview

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content